Hearing Aids and Dementia (Last Updated: Jul 6, 2023)
Project Line:
Horizon Scan
Project Status:
Completed
Search
Evidence on Topics Related to Aging and Health
Remove
Bladder Scanners in Personal Care Homes (Last Updated: Feb 21, 2023)
Project Line:
Health Technology Review
Project Status:
Completed
Oseltamivir for the Prevention of Influenza in Residents of Long-Term Care Facilities (Last Updated: Nov 29, 2022)
Project Line:
Health Technology Review
Project Status:
Completed
faricimab (Vabysmo) (Last Updated: Nov 16, 2022)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Vabysmo
Manufacturer:
Hoffmann-La Roche Ltd.
Submission Type:
Initial
Indications:
For the treatment of Neovascular (wet) age-related macular degeneration (nAMD).
Therapeutic Support for Pressure Injuries (Last Updated: Sep 15, 2022)
Project Line:
Health Technology Review
Project Status:
Completed
ospemifene (Osphena) (Last Updated: Aug 11, 2022)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Osphena
Manufacturer:
Duchesnay Inc.
Submission Type:
Initial
Indications:
Osphena is indicated in postmenopausal women for the treatment of moderate to severe dyspareunia and/or vaginal dryness, symptoms of vulvar and vaginal atrophy (VVA), a component of genitourinary syndrome of menopause (GSM).
Understanding the Portrait of Dementia Care in Canada: Our Panel of Experts (Last Updated: Aug 10, 2022)
As the number of Canadians living with dementia rises, so does the demand for dementia-related care across the country. We facilitated a roundtable discussion to hear about clinicians’ perspectives...
Project Line:
Horizon Scan
Project Status:
Completed
Private IV Infusion Clinics in Canada (Last Updated: Jun 24, 2022)
With the number of IV infusion therapies approved in Canada on the rise, and several in the pipeline for potential future approval, Canada's Drug Agency is assessing the readiness of the Canadian...
Project Line:
Health Technology Review
Project Status:
Completed
Utilization of Cholinesterase Inhibitors for Alzheimer’s Disease in Canada (Last Updated: Jun 13, 2022)
Alzheimer disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide. The cholinesterase inhibitors (ChEIs) donepezil, galantamine, and rivastigmine are first...
Project Line:
Health Technology Review
Project Status:
Completed
An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer Disease (Last Updated: May 16, 2022)
Alzheimer disease is a progressive neurologic condition that leads to the decline of cognitive functioning and eventual death. Proposed causes of Alzheimer disease include the amyloid hypothesis...
Project Line:
Horizon Scan
Project Status:
Completed